Amlo Biosciences

Developer of a prognostic test for the early detection of cancer

placeNewcastle Upon Tyne, England, United Kingdom calendar_todayFounded 2017 groups11 employees language amlo-biosciences.com

Registered entities

Innovation

9 patent families (4 granted) — focus: Physics & computing, Chemistry & metallurgy; filing pace steady. Cited 305 times.

YearFilings
20171
20196
20205
20213
20224
20231
20243
20256

Investor mix

18 investors on record; lead investors include Northstar Ventures, Esperante, North East Fund, Milltrust International Group.

Investor typeCountShare
Venture capital739%
Angel & family office16%
Accelerator & incubator16%
Other / undisclosed950%
Coming soon